More on PULS
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $49.70 |
|
|||
| Open | $49.71 | ||||
| 52 Wk High | $4.00 | ||||
| 52 Wk Low | $0.75 | ||||
| Day High | $49.72 | ||||
| Day Low | $49.70 | ||||
| P/E | N/A | ||||
| EPS | $-4.60 | ||||
| Volume | 7,798,797 | ||||
- Pulsenmore Announces Full Year 2025 Financial Results and Webcast
- Pulsenmore Announces Full Year 2025 Earnings Conference Call
- Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance
- Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center
- Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation
- Form 6-K Pulsenmore Ltd. For: Jan 21
- Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
- Form CERT Pulsenmore Ltd.
- Form 20FR12B Pulsenmore Ltd.
- Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S.
Entities mentioned with PULS
- Earnings | View Related Stories »
- Needham & Company | View Related Stories »
- FDA | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Trading Radar | View Related Stories »
- 13D | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDIC | View Related Stories »
- Show More...
